Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar in T2D and Recent ACS (ALECARDIO)
NCT01042769Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2010
- Primary completion
- Nov 2013
- Countries
- 27
01
Overview
A Phase 3 trial of aleglitazar in type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), sponsored by Roche. Started Feb 2010; status: completed.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT01042769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042769.